QoL and Self-Efficacy: Prostate Cancer Patient Survey
An online survey exploring self-efficacy and the impact of digital support tools among patients diagnosed with prostate cancer in the UK
Challenges
Understanding Drivers of Treatment Adherence & Self-Management
Existing patient and HCP interviews did not successfully explain why patients interrupt treatment, reduce dosages, or struggle with self-management.
Identifying Effective Patient Engagement Approaches
Limited understanding of how HCP interactions, timely information, and digital solutions can better address patient needs and support sustained treatment adherence.
Objectives & Endpoints
Digital Support
Assess the impact of digital tools on treatment adherence and self-management.
HCP Support
Evaluate the role of HCP support in influencing treatment behaviours.
Information & Wellbeing
Understand how access to information and emotional wellbeing influence adherence outcomes.
Our Approach
Survey Design
The Cancer Survivor Self-Efficacy Scale (CS-SES) and Cancer Behaviour Inventory–Brief Version (CBI-B) were used to assess patients’ confidence and self-efficacy in managing various cancer-related situations, while the Functional Assessment of Cancer Therapy–Prostate (FACT-P) questionnaire was used to assess health-related quality of life (HRQoL). All measures were based on patients’ responses to a series of targeted questions.
Online Media Outreach Campaign
Conducted an online survey targeting patients with Prostate Cancer in 3 subgroups: localized, locally advanced & metastatic.
Key Findings
Digital Tools & Self-Management: Use of digital tools for communication, monitoring, and accessing health information showed potential to support self-management.
HRQoL & Self-Efficacy: Patients with higher HRQoL scores reported significantly higher self-efficacy.
Active Treatment Participation: Active involvement in treatment decisions was associated with higher self-efficacy and self-management scores across patient subgroups.
Business Impact & Outcomes
Provided evidence for targeted patient support strategies, including improved communication approaches and digital solutions tailored to patient needs.
Generated insights to guide future patient engagement initiatives aimed at improving quality of life and treatment experience.
Supported Scientific Publication and evidence generation.
*Campaign Days Refers to the number of days between the first and last day of survey completions